Evidence from Europe on implementation, participation and performance of self-collection for cervical cancer screening

被引:0
作者
Huntington, Susie [1 ]
Smith, Jennifer S. [2 ]
Nuttall, Dave [3 ,4 ]
Polokaova, Andrea [1 ]
Smith, Phoebe Marson [1 ]
Hamlyn-Williams, Charlotte [1 ]
Adams, Elisabeth [1 ]
机构
[1] Aquarius Populat Hlth, London, England
[2] UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA
[3] Trinity Coll Dublin, Sch Med, Discipline Histopathol, Dublin, Ireland
[4] CERVIVA Irish Cerv Screening Consortium, Dublin, Ireland
关键词
cancer prevention; cervical cancer; HPV; human papillomavirus; screening; REACH WOMEN; POPULATION; ATTENDANCE; SAMPLES;
D O I
10.1080/14796694.2024.2409625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer screening programs reduce the number of cervical cancer cases and deaths, but the success of any screening program is dependent on high participant uptake and coverage and many European countries are observing declining cervical cancer screening coverage to below national targets. Self-collection of vaginal samples for human papillomavirus testing, also termed self-sampling, is one strategy which is being introduced to try to increase screening coverage by removing barriers to participation and it has attracted growing interest and support globally. Informed by peer-reviewed and gray literature, this narrative review starts with a case study from the Netherlands and outlines the self-collection landscape in Europe within the themes of program implementation and relative test performance. It highlights some of the current evidence gaps needed to inform policy decisions on the use of self-collection within screening programs.
引用
收藏
页数:12
相关论文
共 70 条
  • [1] HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
    Aasbo, Gunvor
    Trope, Ameli
    Nygard, Mari
    Christiansen, Irene Kraus
    Baasland, Ingrid
    Iversen, Grete Alrek
    Munk, Ane Cecilie
    Christiansen, Marit Halonen
    Presthus, Gro Kummeneje
    Undem, Karina
    Bjorge, Tone
    Castle, Philip E.
    Hansen, Bo T.
    [J]. BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1816 - 1826
  • [2] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    [J]. PLOS ONE, 2015, 10 (03):
  • [3] Aitken CA., 2022, EVALUATION DUTCH CER
  • [4] Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study
    Aitken, Clare A.
    Inturrisi, Federica
    Kaljouw, Sylvia
    Nieboer, Daan
    Siebers, Albert G.
    Melchers, Willem J. G.
    van den Brule, Adriaan J. C.
    Molijn, Anco
    Hinrichs, John W. J.
    Niesters, Hubert G. M.
    van Kemenade, Folkert J.
    Berkhof, Johannes
    de Kok, Inge M. C. M.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (02) : 183 - 192
  • [5] Investigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics
    Aitken, Clare A.
    Kaljouw, Sylvia
    Siebers, Albert G.
    Bron, Matilde
    Morssink, Anne
    van Kemenade, Folkert J.
    de Kok, Inge M. C. M.
    [J]. PREVENTIVE MEDICINE REPORTS, 2021, 22
  • [7] HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions
    Arbyn, Marc
    Costa, Stefanie
    Latsuzbaia, Ardashel
    Kellen, Eliane
    Rossi, Paolo Girogi
    Cocuzza, Clementina E.
    Basu, Partha
    Castle, Philip E.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (02) : 159 - 163
  • [8] Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening
    Arbyn, Marc
    Castle, Philip E.
    Schiffman, Mark
    Wentzensen, Nicolas
    Heckman-Stoddard, Brandy
    Sahasrabuddhe, Vikrant V.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (02) : 308 - 312
  • [9] The European response to theWHOcall to eliminate cervical cancer as a public health problem
    Arbyn, Marc
    Gultekin, Murat
    Morice, Philippe
    Nieminen, Pekka
    Cruickshank, Maggie
    Poortmans, Philip
    Kelly, Daniel
    Poljak, Mario
    Bergeron, Christine
    Ritchie, David
    Schmidt, Dietmar
    Kyrgiou, Maria
    Van den Bruel, Ann
    Bruni, Laia
    Basu, Partha
    Bray, Freddie
    Weiderpass, Elisabete
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (02) : 277 - 284
  • [10] Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
    Arbyn, Marc
    Smith, Sara B.
    Temin, Sarah
    Sultana, Farhana
    Castle, Philip
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 363